Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	74.31	-3.44	-13.41
Graham Fair Price	46.75	8240.17	5614.96
PEG	-15.87	0.05	-0.06
Price/Book	-0.50	0.42	0.42
Price/Cash Flow	25.16	32.68	-26.11
Prices/Earnings	-55.12	6.13	13.66
Price/Sales	-8.25	1.32	1.43
Price/FCF	25.16	32.68	-26.11
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-0.56	0.18	0.19
Operating Margin	8.65	0.06	0.05
ROA	151.09	0.01	< 0.005
ROE	< 0.005	0.02	121.73
ROIC	0.01	0.02	36.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.02	-0.10	75.85
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.88	0.16	-81.68
EPS QOQ	2.22	1.19	-46.66
FCF QOQ	-2.36	1.78	-24.58
Revenue QOQ	0.05	0.07	46.08
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	62.90	65.23	3.71
Inventory Turnover	79096936686.00	0.00	inf
Debt/Capitalization	0.01	0.01	3.62
Quick Ratio	4.33	4.66	7.59
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13478.47	15913.60	18.07
Cash	10197.00	7341.03	-28.01
Capex	-5.27	10.63	101.84
Free Cash Flow	-217.50	170.42	-21.65
Revenue	3962.41	4235.19	6.88
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	4.58	4.66	1.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-33.33	-20.67	37.98
Naive Interpretation	Member

06 - Financial Health · Bad

Rating